Adjunct treatment to inhibit renal drug excretion

Adjunct treatment to inhibit renal drug excretion is a pharmacologic intervention rather than a primary disease or clinical syndrome

Adjunct treatment to inhibit renal drug excretion is a pharmacologic intervention rather than a primary disease or clinical syndrome It represents an intentional pharmacokinetic modulation applied in patients receiving coadministered therapeutics—such as specific beta-lactam antibiotics or antiviral agents—that undergo active renal clearance Physiologically, this approach targets the renal proximal tubules by competitively inhibiting organic anion transporters responsible for active tubular secr...

It represents an intentional pharmacokinetic modulation applied in patients receiving coadministered therapeutics—such as specific beta-lactam antibiotics or antiviral agents—that undergo active renal clearance This suppression of tubular excretion reduces renal clearance, elevating and prolonging systemic drug concentrations to enhance therapeutic efficacy or preventing intracellular accumulation within tubular epithelial cells to mitigate nephrotoxicity

Physiologically, this approach targets the renal proximal tubules by competitively inhibiting organic anion transporters responsible for active tubular secretion

This suppression of tubular excretion reduces renal clearance, elevating and prolonging systemic drug concentrations to enhance therapeutic efficacy or preventing intracellular accumulation within tubular epithelial cells to mitigate nephrotoxicity